ArticleAnti-cancer agents in medicinal chemistry2026
Artichoke Extract Ameliorates CCl4-Induced Hepatocellular Carcinoma in Albino Rats by Regulating the Phosphatidylinositol 3-kinase/serine-threonine Protein Kinase Pathway.
Article in Anti-cancer agents in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phenolic-Rich Extracts from Artichoke By-Products Promote Apoptosis in Human Colorectal Cancer Cell Lines.Nutrients · 2026Article
- Antioxidant and anti-apoptotic effects of curcumin-loaded nanoliposomes against di-n-butyl phthalate-induced hepatorenal damage in rats.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCynara scolymus (Artichoke) is a medicinal plant of significant pharmacological importance, rich in phenolic acids and flavonoids. Therefore, the current research aimed to assess the anticancer properties and potential molecular pathways of Artichoke extract utilizing an HCC rat model induced by Carbon tetrachloride (CCl4).
methodsFifty male albino rats were randomly allocated into five groups: a negative control group (NCG), a positive control group (PCG), an Artichoke protective group (APG), an Artichoke treatment group (ATG), and a cisplatin treatment group (CTG). Blood and liver tissue samples were collected for biochemical and molecular analyses at the end of the experiment. We also performed histological examination of the liver and an immunohistochemistry assay for the significant tumor marker alpha-fetoprotein (AFP) and Nrf-2.
resultsOur data showed higher liver enzymes in PCG compared with NCG. Additionally, we also found a significant decrease in Nrf-2, CAT, SOD, caspase 3, and caspase 9 levels and up-regulation of AKT and PI3K in the PCG relative to the negative control group. On the other hand, our findings suggest that Artichoke extract holds protective and therapeutic potential for effectively treating HCC induced by CCl4, especially in the APG. DISCUSSION: Our findings imply that the impressive antioxidant, apoptotic, and anticancer capabilities of Artichoke extract are due to the combination of the phenolic acids and flavonoids. Consequently, it is advisable to incorporate artichoke as a dietary supplement for individuals with chronic liver conditions.
conclusionWe conclude that the up-regulation of the Caspase 3 and Caspase 9 pathways and the suppression of PI3K/AKT signalling pathways may be the mechanisms behind the anti-tumor actions of artichoke extract.
Indexed as
Identifiers
41510726What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.